Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening-Reference-Cited by-同舟云学术

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening

Published:2009-07 Issue:13 Volume:19 Page:3598-3601
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Kiss Róbert,Polgár Tímea,Kirabo Annet,Sayyah Jacqueline,Figueroa Nicholas C.,List Alan F.,Sokol Lubomir,Zuckerman Kenneth S.,Gali Meghanath,Bisht Kirpal S.,Sayeski Peter P.,Keserű György M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference45 articles.

1. Janus kinases: components of multiple signaling pathways

2. Co-expressed Complementary Fragments of the Human Red Cell Anion Exchanger (Band 3, AE1) Generate Stilbene Disulfonate-sensitive Anion Transport

3. Definition of the Interferon-α Receptor-binding Domain on the TYK2 Kinase

4. JAKS AND STATS: Biological Implications

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton tyrosine kinase inhibitors for multiple sclerosis;Nature Reviews Neurology;2023-04-13

2. Nifuroxazide as JAK2 inhibitor: A binding mode proposal and Hel cell proliferation assay;European Journal of Pharmaceutical Sciences;2021-07

3. A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions;Frontiers in Pharmacology;2018-12-04

4. The JAK2 pathway is activated in idiopathic pulmonary fibrosis;Respiratory Research;2018-02-06

5. ATM Is Required for the Prolactin-Induced HSP90-Mediated Increase in Cellular Viability and Clonogenic Growth After DNA Damage;Endocrinology;2017-11-24